Systematic Approach to Neuroimaging in Headache Disorders:

 

Systematic Approach to Neuroimaging in Headache Disorders: A Clinical Guide 

Dr Neeraj Manikath , Claude.ai

Abstract

Headache disorders represent one of the most common presentations in neurological practice, yet determining when neuroimaging is indicated remains a clinical challenge. While most headaches are primary disorders requiring no imaging, identifying secondary causes demanding urgent intervention is critical. This review provides an evidence-based framework for selecting appropriate neuroimaging modalities in headache evaluation, highlighting clinical "red flags," cost-effective approaches, and practical pearls for neurologists managing these complex patients.

Introduction

Headache accounts for approximately 4% of emergency department visits and is among the top reasons for neurological consultation. The International Classification of Headache Disorders (ICHD-3) categorizes over 200 headache types, broadly divided into primary (migraine, tension-type, cluster) and secondary disorders. While primary headaches affect up to 50% of the global population, less than 1% of headache presentations in primary care represent serious underlying pathology requiring imaging.

The challenge lies in distinguishing benign from life-threatening conditions while avoiding unnecessary imaging, which contributes to healthcare costs, incidental findings, and patient anxiety. This review synthesizes current evidence on neuroimaging strategies in headache disorders.

Clinical Red Flags: The SNOOP4 Mnemonic

The American Headache Society's SNOOP4 criteria identify high-risk features warranting neuroimaging:

S - Systemic symptoms/signs

• Fever, weight loss, malignancy history
• HIV/immunocompromised state
• Pregnancy/postpartum period

N - Neurological symptoms/signs

• Focal deficits, altered consciousness
• Papilledema, meningismus
• Cognitive changes

O - Onset sudden

• Thunderclap headache (peak <1 minute)
• "Worst headache of life"

O - Older age of onset

• New headache after age 50
• Giant cell arteritis considerations

P - Pattern change

• Significant change in established headache pattern
• Increasing frequency or severity

P - Positional

• Worse with Valsalva, cough, exertion
• Postural variation (intracranial hypotension vs. hypertension)

P - Precipitated by cough, exertion, or sexual activity

P - Papilledema or progressive neurological deficit

Pearl #1: The "First or Worst" Rule

Any patient describing their "first severe headache" or "worst headache ever" deserves imaging regardless of examination findings. Subarachnoid hemorrhage (SAH) can present with normal neurological examination in up to 50% of cases initially.

Neuroimaging Modalities: Choosing Wisely

Computed Tomography (CT)

Indications:

• Acute thunderclap headache (SAH sensitivity: 95-100% within 6 hours, decreasing to 85% at 24 hours)
• Trauma-related headache
• Suspected acute stroke or intracranial hemorrhage
• Emergency setting when rapid assessment needed
• Contraindications to MRI (pacemakers, claustrophobia, metal implants)

Advantages:

• Rapid acquisition (2-5 minutes)
• Excellent for acute hemorrhage, skull fractures, bony abnormalities
• Widely available, lower cost than MRI

Limitations:

• Radiation exposure (2-4 mSv)
• Poor sensitivity for posterior fossa lesions (beam-hardening artifact)
• Limited soft tissue resolution
• Misses 5% of small aneurysms <5mm
• Poor for pituitary pathology, venous sinus thrombosis, reversible cerebral vasoconstriction syndrome (RCVS)

Oyster #1: The "Negative CT" Pitfall in SAH

A negative non-contrast CT does not rule out SAH after 6 hours. If clinical suspicion remains high, lumbar puncture examining for xanthochromia or CT angiography (CTA) should follow. Third-generation dual-energy CT has improved sensitivity but LP remains gold standard after 6 hours.

Magnetic Resonance Imaging (MRI)

Indications:

• Subacute to chronic headache with red flags
• Progressive headache over weeks to months
• Abnormal neurological examination
• Headache with seizures
• Atypical features not fitting primary headache criteria
• Immunocompromised patients
• Suspected posterior fossa pathology
• Pituitary region evaluation
• Persistent headache in children

Recommended sequences for headache evaluation:

• T1-weighted (pre and post-gadolinium for suspected masses, meningitis, pituitary lesions)
• T2-weighted/FLAIR (white matter disease, edema, demyelination)
• Diffusion-weighted imaging (DWI) - acute infarction, abscess
• Gradient echo (GRE) or susceptibility-weighted imaging (SWI) - microhemorrhages, cavernomas
• MR venography (MRV) - venous sinus thrombosis
• Fat-suppressed sequences - orbital/sinus disease

Advantages:

• No ionizing radiation
• Superior soft tissue contrast
• Multiplanar capability
• Excellent for posterior fossa, brainstem, pituitary
• Detects cerebral venous thrombosis, arterial dissection, RCVS, posterior reversible encephalopathy syndrome (PRES)

Limitations:

• Time-consuming (30-60 minutes)
• Expensive
• Limited availability
• Contraindications (some devices, pregnancy concerns with gadolinium)
• Less sensitive than CT for acute hemorrhage
• Patient compliance required (motion artifact)

Pearl #2: MRI Brain with and without Contrast

Reserve gadolinium-enhanced sequences for:

• Suspected neoplasm or metastases
• Infectious/inflammatory conditions (meningitis, encephalitis, abscess)
• Pituitary pathology
• Suspected vascular malformations requiring detailed characterization

Non-contrast MRI is adequate for:

• Routine headache screening
• White matter disease assessment
• Structural abnormalities (Chiari malformation)
• Venous sinus thrombosis (with MRV)

Clinical Scenarios and Imaging Algorithms

Scenario 1: Acute Thunderclap Headache

Clinical presentation: Sudden onset, maximum intensity within seconds to minutes, severe intensity

Differential diagnosis:

• Subarachnoid hemorrhage (25%)
• RCVS (10-15%)
• Cervical artery dissection (5%)
• Cerebral venous thrombosis (5%)
• Spontaneous intracranial hypotension
• Pituitary apoplexy
• Primary thunderclap headache (diagnosis of exclusion)

Imaging algorithm:

1. Non-contrast CT head (immediate)
   • If positive for SAH → CTA/digital subtraction angiography (DSA) for aneurysm detection
   • If negative and <6 hours from onset → observe, consider CTA to evaluate for aneurysm
2. If CT negative and >6 hours → Lumbar puncture
   • Opening pressure measurement
   • Cell count, protein, glucose
   • Xanthochromia (spectrophotometry preferred over visual inspection)
3. If LP negative → Consider CTA or MRA + MRV
   • Rule out RCVS (multifocal arterial narrowing)
   • Rule out dissection
   • Rule out venous thrombosis

Hack #1: The CTA First Approach

In centers with high-quality CTA, some protocols proceed directly to CTA after negative non-contrast CT in thunderclap headache, potentially eliminating need for LP if both are negative. However, this approach may miss non-aneurysmal SAH and is not universally accepted. The American College of Radiology (ACR) Appropriateness Criteria still recommend LP after negative CT when SAH suspicion is high.

Scenario 2: Progressive Headache with Papilledema

Clinical presentation: Worsening headache over days to weeks, visual changes, papilledema on fundoscopy

Differential diagnosis:

• Space-occupying lesion (tumor, abscess, hematoma)
• Idiopathic intracranial hypertension (IIH)
• Cerebral venous sinus thrombosis
• Hydrocephalus
• Malignant hypertension

Imaging algorithm:

1. MRI brain with gadolinium + MRV (preferred)

   • Evaluate for mass lesion
   • Assess ventricular size
   • MRV for venous sinus thrombosis
   • Signs of IIH: empty sella, optic nerve sheath distension, posterior globe flattening, transverse sinus stenosis

2. If MRI unavailable → CT head with venography

3. Follow-up: If imaging shows no mass and patent sinuses → LP with opening pressure

   • IIH diagnosis: opening pressure >25 cm H₂O with normal CSF composition

Pearl #3: IIH Imaging Signs

Look for the "IIH triad" on MRI:

• Empty or partially empty sella turcica
• Bilateral optic nerve sheath distension with perioptic subarachnoid space enlargement
• Posterior globe flattening

Transverse sinus stenosis is seen in 90% but may be effect rather than cause.

Scenario 3: New Persistent Headache After Age 50

Clinical considerations:

• Giant cell arteritis (GCA) - most critical diagnosis
• Space-occupying lesion
• Chronic subdural hematoma (especially with anticoagulation/falls)
• Medication overuse headache

Imaging algorithm:

1. Clinical assessment for GCA:
   • ESR, CRP, platelet count
   • If clinical suspicion → temporal artery biopsy (do not delay steroids)
   • Consider temporal artery ultrasound (halo sign) where expertise available
2. MRI brain without contrast
   • Rule out structural lesions, subdural collections
   • Assess for chronic small vessel disease
3. Consider MRA head and neck if clinical suspicion for:
   • Large vessel vasculitis
   • Atherosclerotic disease
   • Dissection

Hack #2: The "Rule of 50s" for GCA

Remember GCA rarely occurs before age 50, and in those over 50 with new headache plus any of the following, ESR/CRP should be checked:

• Scalp tenderness
• Jaw claudication
• Visual symptoms
• Polymyalgia rheumatica symptoms
• Temporal artery abnormality

MRI with vessel wall imaging can show mural enhancement in GCA but temporal artery biopsy remains gold standard.

Scenario 4: Positional Headache

Orthostatic headache (worse upright):

• Differential: Spontaneous intracranial hypotension (SIH), post-LP headache, CSF leak

Imaging for SIH:

1. MRI brain with gadolinium:
   • Diffuse pachymeningeal enhancement
   • Brain sagging (low-lying cerebellar tonsils, reduced pontomesencephalic angle)
   • Subdural fluid collections
   • Venous sinus engorgement
2. MRI spine with fat-saturation T2:
   • Epidural fluid collections
   • CSF leak localization
3. If negative and suspicion high:
   • CT or MR myelography
   • Radionuclide cisternography

Headache worse when supine:

• Differential: Intracranial mass, colloid cyst of third ventricle, posterior fossa lesion

Imaging: MRI brain with gadolinium focusing on third ventricle, posterior fossa

Pearl #4: The "Subdural Hygroma" Clue

In SIH, bilateral subdural hygromas or small hematomas are common findings and should prompt consideration of spontaneous CSF leak even if patient denies clear positional component.

Scenario 5: Headache with Aura in Atypical Circumstances

When to image migraine with aura:

• First episode after age 40
• Progressive aura symptoms
• Aura without headache (late-life migraine accompaniments)
• Prolonged aura (>1 hour)
• Motor aura
• Basilar-type symptoms (diplopia, dysarthria, ataxia)
• Persistent aura despite headache resolution

Imaging:

1. MRI brain without contrast (first-line)

   • Rule out structural mimics: AVM, tumor, stroke
   • White matter hyperintensities are common in migraineurs but extensive burden should prompt investigation for other causes

2. MRA or CTA if vascular malformation suspected

Oyster #2: Migraine-Related White Matter Lesions

Migraineurs, especially with aura, have 3-4 times increased prevalence of white matter hyperintensities on FLAIR/T2. These are typically small, subcortical, and non-progressive. Extensive, confluent, or periventricular lesions should prompt consideration of:

• Multiple sclerosis
• CADASIL (with family history, young stroke, mood disorder)
• CNS vasculitis
• Mitochondrial disorders (MELAS)

Scenario 6: Exertional/Cough/Coital Headache

Primary forms are diagnoses of exclusion

Differential of secondary causes:

• Chiari malformation type I
• Posterior fossa mass
• Colloid cyst
• Spontaneous intracranial hypotension
• RCVS (particularly coital headache)
• Vertebral or carotid dissection
• Pheochromocytoma (paroxysmal headache with hypertension)

Imaging algorithm:

1. MRI brain with gadolinium
   • Focus on posterior fossa, foramen magnum
   • Chiari I: tonsillar descent >5mm below foramen magnum
2. CTA or MRA head and neck
   • Evaluate for RCVS in coital/exertional headache
   • Rule out dissection
3. CSF flow studies if surgical decompression considered for Chiari

Hack #3: The 3-Month Rule for Primary Exertional Headache

Primary exertional, cough, and sexual headaches typically resolve within 3 months. If symptoms persist beyond this or worsen, repeat imaging is warranted even if initial studies were negative.

Scenario 7: Chronic Daily Headache

Clinical presentation: Headache ≥15 days per month for >3 months

Most common causes:

• Chronic migraine
• Medication overuse headache
• New daily persistent headache
• Chronic tension-type headache

Imaging considerations:

• Do not image routinely if typical history and normal examination
• Do image if:
  • Abnormal neurological examination
  • Atypical features
  • Recent pattern change
  • Progressive symptoms
  • Treatment resistance

Imaging choice: MRI brain without contrast

Pearl #5: Choosing Battles in Medication Overuse Headache

In obvious medication overuse headache (analgesics ≥15 days/month or triptans ≥10 days/month for >3 months), imaging is low yield with normal examination. Focus on withdrawal and preventive therapy. However, if symptoms persist 2-3 months after medication withdrawal, reconsider imaging.

Special Populations

Pediatric Headache

Imaging indications are more liberal than adults:

• Age <6 years with severe headache
• Recent onset severe headache
• Occipital location
• Awakening from sleep
• Vomiting without nausea (particularly morning vomiting)
• Abnormal neurological examination
• Neurocutaneous stigmata
• Concerning growth parameters (arrest or acceleration)

Imaging choice: MRI brain without contrast (preferred to avoid radiation)

Pregnant and Postpartum Patients

Unique considerations:

• Eclampsia/PRES
• Cerebral venous thrombosis (highest risk postpartum weeks 1-2)
• RCVS (postpartum weeks 1-3)
• Pituitary apoplexy (Sheehan syndrome)
• Cortical vein thrombosis with hemorrhagic infarction

Imaging approach:

1. Non-contrast MRI brain (safe throughout pregnancy)
2. MRV if venous thrombosis suspected
3. CT without contrast if MRI unavailable (fetal radiation risk low with head CT)
4. Avoid gadolinium unless absolutely necessary (FDA Pregnancy Category C)

Oyster #3: The Postpartum Thunderclap Headache

In postpartum thunderclap headache, RCVS is more common than SAH. If CT and LP are negative, proceed to vessel imaging (MRA or CTA) to evaluate for multifocal arterial narrowing. Repeat vessel imaging in 4-12 weeks should show resolution in RCVS.

Immunocompromised Patients

HIV/AIDS, organ transplant, immunosuppressive therapy, malignancy:

Expanded differential:

• CNS infections (toxoplasmosis, cryptococcal meningitis, PML, CMV)
• Primary CNS lymphoma
• Metastases

Imaging: MRI brain with gadolinium (significantly higher yield than in immunocompetent patients)

Advanced Imaging Techniques

CT Angiography (CTA)

Indications:

• Suspected aneurysm after SAH
• Acute arterial dissection
• RCVS evaluation
• Large vessel occlusion in acute stroke
• Vasculitis screening

Advantages:

• Rapid (5-10 minutes)
• Excellent spatial resolution for vessels >1-2mm
• Less expensive than MRA
• Detects 95-98% of aneurysms >3mm

Limitations:

• Radiation exposure (5-10 mSv)
• Iodinated contrast (nephrotoxicity, allergy risk)
• Venous contamination may obscure small vessels

MR Angiography (MRA) and Venography (MRV)

Time-of-flight (TOF) MRA:

• No contrast required
• Good for intracranial vessels
• Excellent for aneurysm screening (>3mm)
• Limitations: flow-related artifacts, overestimates stenosis

Contrast-enhanced MRA:

• Improved visualization of dissection, vasculitis
• Better for extracranial vessels
• Higher accuracy than TOF

MRV:

• Gold standard for cerebral venous thrombosis diagnosis
• No radiation
• Shows collateral venous drainage

Digital Subtraction Angiography (DSA)

Remains gold standard for:

• Aneurysm characterization and treatment planning
• CNS vasculitis diagnosis (after non-invasive imaging is suggestive)
• RCVS confirmation
• Vascular malformation characterization

Limitations:

• Invasive (1% complication rate: stroke, dissection, groin hematoma)
• Expensive
• Radiation exposure
• Reserved for cases where diagnosis will change management

Pearl #6: When to Escalate to DSA

Consider DSA when:

• CTA/MRA shows suspicious but indeterminate vascular findings
• High clinical suspicion for CNS vasculitis with negative non-invasive imaging
• Treatment planning for identified aneurysm or AVM
• Unexplained thunderclap headache after negative CTA/MRA but continued suspicion for RCVS

High-Resolution Vessel Wall Imaging (VW-MRI)

Emerging technique providing:

• Direct vessel wall visualization
• Differentiation of vasculitis (circumferential enhancement) from atherosclerosis (eccentric)
• Dissection characterization (intramural hematoma)
• RCVS vs. vasculitis distinction
• Intracranial atherosclerotic disease assessment

Clinical applications expanding but not yet standard of care at all centers

Cost-Effectiveness and Avoiding Overuse

The "Choosing Wisely" Principles for Headache Imaging

Do not image:

1. Stable primary headache disorders meeting ICHD-3 criteria with normal examination
2. Chronic headache with no red flags and normal examination
3. Migraine patients with typical aura patterns and normal examination

This approach prevents:

• Unnecessary healthcare expenditure ($1 billion annually in US)
• Incidental findings (found in 15% of scans) leading to cascading investigations
• Patient anxiety and false reassurance
• Radiation exposure from CT scans

Decision Rules and Clinical Prediction Tools

Several validated tools help stratify imaging need:

Ottawa Subarachnoid Hemorrhage Rule (for alert patients with acute headache):

• Age ≥40 years
• Neck pain or stiffness
• Witnessed loss of consciousness
• Onset during exertion
• Thunderclap headache
• Limited neck flexion

If none present: <1% risk of SAH (but should not replace clinical judgment)

Migraine-Specific Quality of Life Questionnaire and MIDAS: Do not predict imaging yield but help assess disability and treatment need

Pearl #7: The "Reassurance CT"

Avoid performing CT "for reassurance" in low-risk headache patients. Studies show negative imaging does not reduce healthcare utilization or patient anxiety long-term, and may actually increase patient concern about the need for imaging. Therapeutic alliance and education are superior to imaging for reassurance.

Management of Incidental Findings

Neuroimaging reveals incidental findings in approximately 15% of headache patients:

Common incidental findings:

• White matter hyperintensities (age-related, migraine-related, or vascular risk factors)
• Arachnoid cysts (typically benign, follow if symptomatic)
• Developmental venous anomalies (benign, no treatment needed)
• Pineal cysts (benign if <1cm, stable, no mass effect)
• Small aneurysms (<7mm without concerning features)
• Meningiomas (95% benign, surveillance vs. surgery depending on size/symptoms)
• Pituitary microadenomas (10% of population, most non-functional)

Hack #4: The Incidental Findings Protocol

Establish a systematic approach:

1. Determine clinical significance: Does it explain headache? Likely not if longstanding headache pattern.
2. Risk stratification: Likelihood of growth/complications
3. Discussion with patient: Benefits and risks of further investigation
4. Surveillance protocol: Most require MRI follow-up in 6-12 months, then annually for 2-3 years if stable

Shared decision-making is crucial: Many incidental findings cause more harm through anxiety and additional testing than the condition itself.

Future Directions

Artificial Intelligence and Machine Learning

AI applications in headache imaging include:

• Automated detection of acute hemorrhage on CT
• Aneurysm detection algorithms (sensitivity approaching 95%)
• Quantification of white matter disease burden
• Prediction models for imaging yield based on clinical features

Advanced MRI Techniques

• Arterial spin labeling (ASL): Perfusion imaging without contrast
• Functional MRI: Headache pathophysiology research
• 7-Tesla MRI: Improved resolution for small vessel disease, microbleeds
• Quantitative susceptibility mapping (QSM): Enhanced detection of calcification, iron deposition

Biomarkers

Research into serum/CSF biomarkers (CGRP, inflammatory markers) may eventually reduce imaging need by better differentiating primary from secondary headaches.

Practical Summary: The 10 Commandments of Headache Imaging

1. Image red flags, not reassurance: SNOOP4 criteria guide appropriate imaging
2. CT for acute thunderclap, MRI for subacute/chronic: Know your modalities
3. Negative CT doesn't exclude SAH after 6 hours: Follow with LP or vascular imaging
4. Primary headaches don't need imaging: If ICHD-3 criteria met and exam normal
5. Age matters: Liberal imaging after 50, consider primary disorders in young adults
6. Gadolinium for infections, tumors, inflammation: Not routine screening
7. Don't forget the vessels: MRV/CTA/MRA for thunderclap, positional, focal deficits
8. Repeat imaging if pattern changes: Even if previously normal
9. Manage incidental findings judiciously: Most don't cause headache
10. Document your decision: When imaging is deferred, note clinical reasoning

Conclusion

Appropriate neuroimaging in headache disorders requires balancing sensitivity for dangerous conditions against specificity to avoid unnecessary testing. A systematic approach using validated red flags, understanding imaging modality strengths and limitations, and applying evidence-based algorithms optimizes patient care while stewarding healthcare resources. As neuroimaging technology advances, the goal remains unchanged: identify the small minority of patients with secondary headaches requiring intervention while confidently managing primary headache disorders clinically.

The art of headache medicine lies not in ordering every available test, but in knowing when imaging is truly indicated and—equally important—when it is not. This clinical judgment, combined with a thorough history and examination, remains the cornerstone of headache evaluation.

---

Key References

1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.

2. Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134-144.

3. Perry JJ, Stiell IG, Sivilotti MLA, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013;310(12):1248-1255.

4. American College of Radiology. ACR Appropriateness Criteria: Headache. Available at: https://acsearch.acr.org/docs/69482/Narrative/

5. Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. Stroke. 2016;47(3):750-755.

6. Schwedt TJ, Chong CD, Wu T, Gaw N, Fu Y, Li J. Accurate classification of chronic migraine via brain magnetic resonance imaging. Headache. 2015;55(6):762-777.

7. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.

8. Schievink WI. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA. 2006;295(19):2286-2296.

9. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11(10):906-917.

10. Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother. 2011;11(9):1265-1276.

11. Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009;8(6):560-568.

12. Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26(5):1012-1021.

13. Evans RW, Burch RC, Frishberg BM, et al. Neuroimaging for migraine: the American Headache Society systematic review and evidence-based guideline. Headache. 2020;60(2):318-336.

14. Choosing Wisely: American Headache Society. Five Things Physicians and Patients Should Question. Available at: https://www.choosingwisely.org/societies/american-headache-society/

15. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.

16. Kupersmith MJ, Hurst R, Berenstein A, et al. The benign course of cavernous carotid artery aneurysms. J Neurosurg. 1992;77(5):690-693.

17. Mandell DM, Mossa-Basha M, Qiao Y, et al. Intracranial vessel wall MRI: principles and expert consensus recommendations. AJNR Am J Neuroradiol. 2017;38(2):218-229.

18. Callaghan BC, Kerber KA, Pace RJ, Skolarus LE, Burke JF. Headaches and neuroimaging: high utilization and costs despite guidelines. JAMA Intern Med. 2014;174(5):819-821.

19. Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006;296(10):1274-1283.

20. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188-1195.

---

This review synthesizes current best evidence for neuroimaging in headache disorders. Individual patient care should be tailored based on clinical judgment, patient preferences, and institutional capabilities.